MannKind Corp
MNKD
#5891
Rank
NZ$2.17 B
Marketcap
NZ$6.78
Share price
1.52%
Change (1 day)
-30.40%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): NZ-$0.12

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is NZ-$0.12. In 2025 the company made an earnings per share (EPS) of NZ$0.03379 a decrease over its 2024 EPS that were of NZ$0.17.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.12-459.37%
2025NZ$0.03379-80%
2024NZ$0.17
2022NZ-$0.576.25%
2021NZ-$0.5428%
2020NZ-$0.42-7.41%
2019NZ-$0.46
2017NZ-$1.88-188.1%
2016NZ$2.13-128.31%
2015NZ-$7.5274.51%
2014NZ-$4.31-20.31%
2013NZ-$5.41-32.63%
2012NZ-$8.03-28.03%
2011NZ-$11.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.21-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$7.26-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$47.69-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.04-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.93-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$14.23 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA